La mutación Christchurch, que protege de la enfermedad de Alzheimer familiar causada por mutaciones en el gen PSEN1, también protege del efecto negativo de la variante APOE4, principal factor de rie...
Read moreProfessionals, experts, and researchers across diverse glycoscience disciplines, encompassing glycobiology, immunology, and carbohydrate chemistry, converge at the 6th edition of Glycobasque.
Read moreThe UAB has launched a new campaign to raise funds to study a gene therapy for adenylsuccinate lyase deficiency (ADSL), a rare genetic disease suffered by about 80 children in the world, including two...
Read moreThe project RECOMB, in which Vall d'Hebron participates, has recently launched a clinical trial to develop a gene therapy to cure patients with SCID, popularly known as "bubble child syndrome" who hav...
Read moreThe Spanish Agency for Medicines and Health Products (AEMPS) defines them advanced therapies as medicines for human use that may be based on genes (gene therapy), cells (cellular therapy) or fabrics (...
Read moreThe Ministry of Science and Innovation has awarded more than 6 million euros to 46 projects led by researchers from the University of Navarra, corresponding to different areas of knowledge.
Read moreEl Ministerio de Ciencia e Innovación ha concedido cerca de 5 millones de euros a 27 proyectos liderados por investigadores de la ClÃnica Universidad de Navarra y del Cima para la lucha contra el cÃ...
Read moreCERTERA's objective is to create a coordinated research and innovation structure to accelerate the preclinical and early stage clinical development of these types of therapies.
Read moreSparingVision today announces a key advancement in its Phase I/II clinical trial for SPVN06, the Company’s lead gene-agnostic investigational gene therapy for the treatment of retinitis pigmentosa (...
Read moreResearchers at the University of Barcelona are participating in a new consortium to design a drug with an innovative approach against this disease, which could also be used to treat other hereditary r...
Read moreDos recientes estudios ofrecen importantes avances en la utilización de terapia génica como tratamiento para la pérdida auditiva.
Read moreVivet Therapeutics announces the financing of EUR 4.9 million received from the French government to advance the development of a gene therapy for the treatment of cerebrotendinous xanthomatosis (CTX)...
Read more